Table 6.

The relationship between the 6 signature lncRNAs and clinicopathological characteristics

Parameter	No.	AC012640.1 expression		P value	GLIS3-AS1 expression		P value	LINC00158 expression		P value
		Low (n=181)	High (n=182)		Low (n=181)	High (n=18)		Low (n=182)	High (n=181)
Age (years)
<60	78	41	37	0.59	44	34	0.192	45	33	0.132
≥60	285	140	145		137	148		137	148
Gender
Female	92	49	43	0.451	51	41	0.216	48	44	0.651
Male	271	132	139		130	141		134	137
T stage
T1 + T2	178	84	94	0.266	101	77	0.005*	88	90	0.791
T3 + T4	179	95	84		75	104		91	88
N stage
N0	225	110	115	0.636	120	105	0.091	110	115	0.543
N1	138	71	67		61	77		72	66
M stage
M0	187	93	94	0.959	99	88	0.227	94	93	0.959
M1	176	88	88		82	94		88	88
Grade stage
Low Grade	20	12	8	0.344	12	8	0.357	14	6	0.07
High Grade	342	168	174		169	173		168	174
Pathological stage
Stage I+II	118	56	62	0.525	72	46	0.003*	56	62	0.478
Stage III+IV	245	125	120		109	136		126	119
Parameter	No.	MEG8 expression		P value	NAV2-AS2 expression		P value	STEAP3-AS1 expression		P value
		Low (n=181)	High (n=182)		Low (n=182)	High (n=181)		Low (n=182)	High (n=181)
Age (years)
<60	78	50	28	0.005*	48	30	0.023*	33	45	0.119
≥60	285	131	154		134	151		149	136
Gender
Female	92	44	48	0.651	52	40	0.156	39	53	0.085
Male	271	137	134		130	141		143	128
T stage
T1 + T2	178	98	80	0.03*	100	78	0.023*	94	84	0.368
T3 + T4	179	78	101		79	100		86	93
N stage
N0	225	123	102	0.019*	117	108	0.365	119	106	0.181
N1	138	58	80		65	73		63	75
M stage
M0	187	108	79	0.002*	107	80	0.005*	88	99	0.227
M1	176	73	103		75	101		94	82
Grade stage
Low Grade	20	16	4	0.006*	16	4	0.006*	13	7	0.167
High Grade	342	165	177		166	176		168	174
Pathological stage
Stage I+II	118	76	42	0*	70	48	0.015*	63	55	0.39
Stage III+IV	245	105	140		112	133		119	126

Abbreviations: The six lncRNAs were divided into 'high' and 'low' lncRNA expression group according to the median value; *Statistically significant.